VOR
Vor Biopharma Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Jean-Paul Kress
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Vor Biopharma Inc.
CEO
Jean-Paul Kress
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 57,162 |
| $14.09 |
| 12 Jun 2026 | Namouni Fouad | director | A-Award | Acquired | 56,549 | $14.09 |
| 12 Jun 2026 | Joustra Wouter | director | A-Award | Acquired | 57,162 | $14.09 |
| 12 Jun 2026 | Kalir Erez | director | A-Award | Acquired | 57,162 | $14.09 |
| 12 Jun 2026 | Cumbo Alexander | director | A-Award | Acquired | 56,345 | $14.09 |
| 12 Jun 2026 | Beckman Daniella | director | A-Award | Acquired | 53,283 | $14.09 |
| 12 Jun 2026 | Levin Andrew David | director | A-Award | Acquired | 57,162 | $14.09 |
| 24 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | S-Sale | Disposed | 165,150 | $15.77 |
| 21 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | S-Sale | Disposed | 458,411 | $16.28 |